Inventor · disambiguated record
Yatindra Joshi
Also filed as: JOSHI YATINDRA · JOSHI YATINDRA M
7 granted patents·26 pending applications·514 citations·filing 1987–2023
86Inventor score
Top patents by PatentIndex Score
33 records- 0193US5180589APravastatin pharmaceuatical compositions having good stabilitySQUIBB & SONS INC·Filed 1991·Granted Jan 19, 1993·182 cites·12 claims
- 0293US5030447APharmaceutical compositions having good stabilitySQUIBB & SONS INC·Filed 1988·Granted Jul 9, 1991·191 cites·13 claims
- 0389US4808413APharmaceutical compositions in the form of beadlets and methodSQUIBB & SONS INC·Filed 1987·Granted Feb 28, 1989·134 cites·35 claims
- 0483US8475839B2Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the sameCAO YU·Filed 2012·Granted Jul 2, 2013·7 cites·7 claims
- 0564US2009060848A1Pharmaceutical composition which reduces or eliminates drug abuse potentialJOSHI YATINDRA·Filed 2008·Application pending·0 cites
- 0664US2023364094A1Deuterated ruc-4CELECOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0762US11684622B2Deuterated RUC-4CELECOR THERAPEUTICS INC·Filed 2019·Granted Jun 27, 2023·0 cites·20 claims
- 0860US2007148247A1Pharmaceutical composition which reduces or eliminates drug abuse potentialJOSHI YATINDRA·Filed 2007·Application pending·0 cites
- 0959US2004042964A1Pharmaceutical composition which reduces or eliminates drug abuse potentialFiled 2003·Application pending·0 cites
- 1055US2009149543A1Solid pharmaceutical compositions comprising lumiracoxibKARNACHI ANEES ABDULQUADAR·Filed 2009·Application pending·0 cites
- 1153US2002187192A1Pharmaceutical composition which reduces or eliminates drug abuse potentialFiled 2001·Application pending·0 cites
- 1253US2010003321A1Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the sameCAO YU·Filed 2007·Application pending·0 cites
- 1353US2003147975A1Pharmaceutical composition which produces irritationFiled 2003·Application pending·0 cites
- 1451US2025281490A1Ruc-4 formulationsCELECOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1551US2010152299A1Process for making compositions with poorly compressible therapeutic compoundsVASANTHAVADA MADHAV·Filed 2006·Application pending·0 cites
- 1650US2007087051A1Pharmaceutical compositionHOLINEJ JURIJ·Filed 2006·Application pending·0 cites
- 1749US2003049272A1Pharmaceutical composition which produces irritationFiled 2001·Application pending·0 cites
- 1848US2008171086A1Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the SameJOSHI YATINDRA·Filed 2006·Application pending·0 cites
- 1947US8323688B2Pharmaceutical compositions comprising hGH for oral deliveryAZRIA MOISE·Filed 2007·Granted Dec 4, 2012·0 cites·14 claims
- 2047US2014287040A1FormulationJOSHI YATINDRA·Filed 2014·Application pending·0 cites
- 2145US2008227825A1FormulationJOSHI YATINDRA·Filed 2006·Application pending·0 cites
- 2244US2012077879A1Process for making compositions with poorly compressible therapeutic compoundsVASANTHAVADA MADHAV·Filed 2011·Application pending·0 cites
- 2344US2012177733A1Solid dosage forms of valsartan and amlodipine and method of making the sameJOSHI YATINDRA·Filed 2012·Application pending·0 cites
- 2444US2003171437A1Pharmaceutical compositionFiled 2003·Application pending·0 cites
- 2544US2005123604A1Pharmaceutical compositionsFiled 2003·Application pending·0 cites
- 2643US8410052B2Oral administration of a calcitoninJOSHI YATINDRA·Filed 2008·Granted Apr 2, 2013·0 cites·14 claims
- 2743US2013052239A1FormulationJOSHI YATINDRA·Filed 2012·Application pending·0 cites
- 2841US2010303906A1Solid dosage forms of valsartan and amlodipine and method of making sameJOSHI YATINDRA·Filed 2010·Application pending·0 cites
- 2941US2010035949A1Microemulsion dosage forms of valsartan and methods of making the sameJOSHI YATINDRA·Filed 2007·Application pending·0 cites
- 3041US2010021539A1Modified Release 1-[(3-Hydroxy-Adamant-1-Ylamino)-Acetyl]-Pyrrolidine-2(S)-Carbonitrile FormulationKOWALSKI JAMES·Filed 2006·Application pending·0 cites
- 3139US2011045062A1FormulationJOSHI YATINDRA·Filed 2010·Application pending·0 cites
- 3238US2011086096A1Modified release 1- [ (3-hydroxy-adamant-1-ylamino)-acetyl] -pyrrolidine-2 (s) -carbonitrile formulationKOWALSKI JAMES·Filed 2010·Application pending·0 cites
- 3337US2008050443A1Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing ThereofKOWALSKI JAMES·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →